Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.50
Bid: 60.00
Ask: 75.00
Change: 6.00 (8.57%)
Spread: 15.00 (25.00%)
Open: 70.00
High: 76.00
Low: 67.50
Prev. Close: 70.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Biome receives £282k grant

16 Nov 2022 07:00

RNS Number : 5289G
Biome Technologies PLC
16 November 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

16 November 2022

 

Biome Technologies plc

 

("Biome", "the Company" or "the Group")

 

Biome receives £282k grant to scale-up novel biopolymers

 

Biome announces that its Bioplastics division (www.biomebioplastics.com) has been awarded £282,000 in funding from Innovate UK, the UK Government's innovation agency, to support the scale-up of novel compostable biopolymers for the flexible packaging and coatings industries in collaboration with Thomas Swan (www.thomas-swan.co.uk) and the University of Nottingham. The project has a total investment of £474,000 and is expected to last 18 months.

Over the last nine years, Biome has undertaken considerable research and development work on a range of biodegradable polymers, based on bio-based inputs. This work has involved seven universities and around 30 leading scientists and engineers. All the resultant polymers are subject to patent protection or patent application. Before this new Innovate UK grant, these novel polymers have only been scaled successfully from laboratory test-tube to small kilogram quantities on pilot plant equipment.

 

The new funding for this project will scale up one of these promising polymers to quantities of hundreds of kilograms on Thomas Swan's industrial-scale assets. This selected polymer is based on furan dicarboxylic acid (FDCA), an important new bio-based chemical. Such production will allow the performance and production process of this polymer to be evaluated at a commercially relevant scale.

 

Thomas Swan is a leading independent manufacturer of performance and fine chemicals with offices in the United States and China and a global network of distributors. The company manufactures over 100 products, from kilogram to multi-tonne quantities, and offers an experienced and flexible custom manufacturing service. Thomas Swan has collaborated with Biome's development for the last few years and is well-placed to support this specific project and ultimately manufacture Biome's novel FDCA based polymers at a commercial scale.

 

The University of Nottingham has worked with Biome for the past five years. Its contribution to this project will be led by Derek Irvine, Professor of Materials Chemistry at the institution's Faculty of Engineering. His team will support the technology transfer from the laboratory to Thomas Swan and work on further enhancements to the FDCA-derived polymer.

 

This work forms part of Biome's approach to providing highly functional added-value products to the market. It is envisaged that products derived from this collaboration will be commercialised after project completion.

 

Paul Mines, Biome Technologies' Chief Executive, commented:

 

"After nine years of significant work by Biome's scientists, engineers and supporting partners, it is great to be taking a substantial step towards industrialisation in bringing these FDCA-based polymers to the market. Thomas Swan and the University of Nottingham are great partners to support us on our journey to commercialise this new generation of bio-based and compostable polymers."

 

Harry Swan, Thomas Swan's Chief Executive and Owner, added:

 

"This is an excellent project that will see the acceleration of an important new sustainable product for Biome. It also sits well with Thomas Swan's own mission to inspire and deliver sustainable chemistry. Innovate UK grants are not easy to secure which lends great credibility to the technology and its potential. I look forward to seeing this exciting project progress with our partners, Biome and the University of Nottingham."

 

-Ends-

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited ("Bioplastic") and Stanelco RF Technologies Limited ("RF Technologies").

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil- based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

www.biometechnologiesplc.com www.biomebioplastics.com and www.thinkbioplastic.com www.stanelcorftechnologies.com

 

About Thomas Swan

Thomas Swan & Co. Ltd. is an independent chemical manufacturing company. With offices and warehousing in the UK, USA and China and a global network of distributors, they service the domestic and international markets and export to over 80 countries worldwide.

Founded in 1926 in Consett, in the North East of England - still home to their manufacturing facilities - Thomas Swan today produces over 100 products, in kilogramme to multi-tonne quantities, and offers an experienced and flexible manufacturing service.

www.thomas-swan.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFELLFLFLZFBQ
Date   Source Headline
15th Jan 20084:35 pmRNSPrice Monitoring Extension
15th Jan 20082:28 pmRNSNotifiable Interest
14th Jan 20087:00 amRNSPre Close Update
9th Jan 20084:25 pmRNSHolding(s) in Company
4th Dec 20074:40 pmRNSSecond Price Monitoring Extn
4th Dec 20074:35 pmRNSPrice Monitoring Extension
26th Nov 20074:35 pmRNSPrice Monitoring Extension
25th Sep 20079:54 amRNSNotifiable Interest
10th Sep 20077:02 amRNSInterim Results
28th Aug 20072:33 pmRNSNotifiable Interest
30th Jul 20074:37 pmRNSNotifiable Interest
30th Jul 20074:35 pmRNSNotifiable Interest
27th Jul 20071:56 pmRNSNotifiable Interest
6th Jul 20077:01 amRNSTrading Statement
5th Jul 20076:19 pmRNSDirector Dealings
29th Jun 200712:26 pmRNSTotal Voting Rights
6th Jun 20074:14 pmRNSAdditional Listing
29th May 20075:29 pmRNSDisposal of Assets
29th May 20077:02 amRNSTrading Statement
27th Apr 20071:34 pmRNSResult of AGM
27th Apr 20071:32 pmRNSDirectorate Change
26th Apr 20071:42 pmRNSAnnual Information Update
13th Apr 200712:29 pmRNSDirector's Dealing
30th Mar 20071:32 pmRNSAnnual Report and Accounts
23rd Mar 20075:09 pmRNSNotifiable Interest
21st Mar 20077:03 amRNSPreliminary Results
14th Mar 20075:59 pmRNSHolding(s) in Company
26th Feb 20077:01 amRNSBoard Appointment
23rd Feb 20073:18 pmRNSHolding(s) in Company
30th Jan 20079:00 amRNSNotice of Results
18th Dec 20064:58 pmRNSTotal Voting Rights
8th Dec 200612:31 pmRNSNotifiable Interest
28th Nov 20063:32 pmRNSNotifiable Interest
17th Nov 20063:33 pmRNSNotifiable Interest
16th Nov 20069:02 amRNSNotifiable Interest
14th Nov 20064:37 pmRNSDirectorate Change
14th Nov 20064:09 pmRNSDirector/PDMR Shareholding
14th Nov 20064:03 pmRNSNotifiable Interest
14th Nov 20069:55 amRNSNotifiable Interest
10th Nov 200610:29 amRNSHolding(s) in Company
9th Nov 200611:45 amRNSNotifiable Interest
8th Nov 20063:08 pmRNSNotifiable Interest
7th Nov 20068:01 amRNSIssue of Equity
6th Nov 200612:12 pmRNSResult of EGM
3rd Nov 20064:41 pmRNSNotifiable Interest
3rd Nov 20061:17 pmRNSOpen Offer Result - Amendment
2nd Nov 20066:03 pmRNSOpen Offer Result
31st Oct 200611:54 amRNSNotifiable Interest
17th Oct 20065:54 pmRNSNotifiable Interest
17th Oct 200610:44 amRNSNotifiable Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.